Adverum Biotechnologies, Inc.
Q4 2024 13F Holders
Symbol
ADVM
CUSIP
00773U207
Type
Equity
Class
COM NEW
Num filings
72
Total reported value, excl. options
$71.8 M
Compare 2024 Q4 to
2025 Q3
2025 Q2
2025 Q1
2024 Q3
2024 Q2
2024 Q1
Manager
Report Date
Value ($000)
Shares
Option Type